These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 7557659)

  • 1. [Long-term follow-up in polycythemia vera].
    Cohen-Goldenberg N; Shpilberg O; Modan B; Chetrit A; Ramot B
    Harefuah; 1995 Jun; 128(11):673-6, 744. PubMed ID: 7557659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic recommendations in polycythemia vera based on Polycythemia Vera Study Group protocols.
    Berk PD; Goldberg JD; Donovan PB; Fruchtman SM; Berlin NI; Wasserman LR
    Semin Hematol; 1986 Apr; 23(2):132-43. PubMed ID: 3704665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Polycythemia vera as a multiphasic clonal panmyelopathy: diagnostic profile, chronic pathological progression and effect of therapy on the survival of 74 cases].
    Sánchez Fayos J; Prieto E; Román A; Soto de Ozaeta C; Nevado I; Richart A; Chica E; Loscertales J; Calabuig T; Benítez J; Outeiriño J
    Sangre (Barc); 1996 Dec; 41(6):447-57. PubMed ID: 9148422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The very long-term evolution of polycythemia vera: an analysis of 318 patients initially treated by phlebotomy or 32P between 1969 and 1981.
    Najean Y; Rain JD
    Semin Hematol; 1997 Jan; 34(1):6-16. PubMed ID: 9025157
    [No Abstract]   [Full Text] [Related]  

  • 5. Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments.
    De Stefano V; Za T; Rossi E; Vannucchi AM; Ruggeri M; Elli E; Micò C; Tieghi A; Cacciola RR; Santoro C; Gerli G; Vianelli N; Guglielmelli P; Pieri L; Scognamiglio F; Rodeghiero F; Pogliani EM; Finazzi G; Gugliotta L; Marchioli R; Leone G; Barbui T;
    Haematologica; 2008 Mar; 93(3):372-80. PubMed ID: 18268279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Efficacious treatment of a fatal blood disease: polycythemia vera].
    Sánchez Fayos J; Román Barbero A; Nevado Reviriego I
    Sangre (Barc); 1997 Jun; 42(3):215-8. PubMed ID: 9381264
    [No Abstract]   [Full Text] [Related]  

  • 7. Splenectomy after portal thrombosis in patients with polycythemia vera and essential thrombocythemia.
    Randi ML; Fabris F; Ruzzon E; Pacquola E; Cella G; Girolami A
    Haematologica; 2002 Nov; 87(11):1180-4. PubMed ID: 12414348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leukemogenic risk of hydroxyurea therapy in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis.
    Nand S; Stock W; Godwin J; Fisher SG
    Am J Hematol; 1996 May; 52(1):42-6. PubMed ID: 8638610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of arterial compliance in polycythemia vera patients: short and long-term influence of phlebotomy.
    Nemets A; Isakov I; Huerta M; Barshai Y; Oren S; Lugassy G
    Isr Med Assoc J; 2006 Dec; 8(12):845-7. PubMed ID: 17214101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurologic complications of polycythemia and their impact on therapy.
    Newton LK
    Oncology (Williston Park); 1990 Mar; 4(3):59-64; discussion 64-6. PubMed ID: 2144446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Association of polycythemia vera and multiple myeloma. Presentation ofa new case and review of the literature].
    Prósper F; Paloma MJ; Rifón J; Cuesta B; Hermida J; Rocha E
    Sangre (Barc); 1993 Dec; 38(6):497-9. PubMed ID: 8171387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Principia of cancer therapy. IV. Induction of hemoconcentration for phlebotomy in polycythemia vera.
    Okuyama S; Mishina H; Ito Y; Matsuzawa T
    Sci Rep Res Inst Tohoku Univ Med; 1983 Dec; 30(1-4):29-30. PubMed ID: 6678498
    [No Abstract]   [Full Text] [Related]  

  • 13. [Polycythaemia vera--diagnosis and therapy].
    Lechner K; Geissler K; Gisslinger H
    Wien Klin Wochenschr; 1999 Aug; 111(15):582-9. PubMed ID: 10483672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leukemic transformation of polycythemia vera after treatment with hydroxyurea with abnormalities of chromosome 17.
    Tóthová E; Fricová M; Stecová N; Hlebasková M; Kafková A; Raffac S; Guman T; Svorcová E; Nebesnáková E
    Neoplasma; 2001; 48(5):389-92. PubMed ID: 11845984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chronic progressive polycythemia and thrombocytosis].
    Forkert R; Ko Y; Fronhoffs S; Tschubel K; Vetter H
    Praxis (Bern 1994); 2001 Apr; 90(17):741-6. PubMed ID: 11387815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term effects of the treatment of polycythemia vera with recombinant interferon-alpha.
    Silver RT
    Cancer; 2006 Aug; 107(3):451-8. PubMed ID: 16804923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk stratification, staging, and treatment of patients with polycythemia vera: Italian and European collaboration on low-dose aspirin in polycythemia data.
    Finazzi G
    Semin Thromb Hemost; 2006 Apr; 32(3):276-82. PubMed ID: 16673282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of polycythemia. I--Using radiophosphorus with or without treatment in 483 patients over 65 years of age].
    Najean Y; Rain JD; Goguel A; Grange MJ; Vigneron N; Dupuy E; Mougeot-Martin M
    Ann Med Interne (Paris); 1998 Mar; 149(2):87-93. PubMed ID: 11490530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polycythemia vera: plethora, from prehistory to present.
    Steensma DP
    Curr Hematol Rep; 2005 May; 4(3):230-4. PubMed ID: 15865877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Choice of treatment in polycythemia vera. 2. Long term course in 286 patients treated with P-32].
    Rain JD; Dresch C; Saïd A; Najean Y
    Nouv Presse Med; 1973 Jun; 2(22):1499-503. PubMed ID: 4711708
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.